UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma

Science translational medicine, 2018-11, Vol.10 (467)

2018

Volltextzugriff (PDF)

Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma

Cancer research (Chicago, Ill.), 2017-11, Vol.77 (22), p.6119-6130

2017

Volltextzugriff (PDF)

Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis

Nature communications, 2021-07, Vol.12 (1), p.4172-4172, Article 4172

2021

Volltextzugriff (PDF)

Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices

BMC health services research, 2019-10, Vol.19 (1), p.701-701, Article 701

2019

Volltextzugriff (PDF)

Characteristics of Lung Cancers Harboring NRAS Mutations

Clinical cancer research, 2013-05, Vol.19 (9), p.2584-2591

2013

Volltextzugriff (PDF)

Aromatase inhibitors in human lung cancer therapy

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (24), p.11287-11291

2005

Volltextzugriff (PDF)

A Phase I Trial to Determine the Optimal Biological Dose of Celecoxib when Combined with Erlotinib in Advanced Non–Small Cell Lung Cancer

Clinical cancer research, 2006-06, Vol.12 (11), p.3381-3388

2006

Volltextzugriff (PDF)

Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 + T-cell Infiltration

Clinical cancer research, 2017-08, Vol.23 (16), p.4556-4568

2017

Volltextzugriff (PDF)

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer

BMC cancer, 2009-06, Vol.9 (1), p.213-213, Article 213

2009

Volltextzugriff (PDF)

COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California

JAMA network open, 2021-09, Vol.4 (9), p.e2127582-e2127582

2021

Volltextzugriff (PDF)

Regression of Recurrent Respiratory Papillomatosis With Celecoxib and Erlotinib Combination Therapy

Chest, 2009-09, Vol.136 (3), p.924-926

2009

Volltextzugriff (PDF)

Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma

American journal of otolaryngology, 2012-01, Vol.33 (1), p.6-13

2012

Volltextzugriff (PDF)

Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers

Clinical cancer research, 2006-01, Vol.12 (1), p.314-320

2006

Volltextzugriff (PDF)

Challenge and opportunity of targeted lung cancer chemoprevention

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4169-4171

2013

Volltextzugriff (PDF)

Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer

Journal of cancer research and clinical oncology, 2014-03, Vol.140 (3), p.443-452

2014

Volltextzugriff (PDF)

Gene Expression Alterations in the Bronchial Epithelium of e-Cigarette Users

Chest, 2019-10, Vol.156 (4), p.764-773

2019

Volltextzugriff (PDF)

Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2018-09, Vol.123, p.91-98

2018

Volltextzugriff (PDF)

Randomized phase 2 trial of erlotinib in combination with high‐dose celecoxib or placebo in patients with advanced non‐small cell lung cancer

Cancer, 2015-09, Vol.121 (18), p.3298-3306

2015

Volltextzugriff (PDF)

Modulation of Pulmonary Leukotriene B4 Production by Cyclooxygenase-2 Inhibitors and Lipopolysaccharide

Clinical cancer research, 2004-10, Vol.10 (20), p.6872-6878

2004

Volltextzugriff (PDF)

Histopathologic findings of HPV and p16 positive HNSCC

The Laryngoscope, 2010-09, Vol.120 (9), p.1788-1794

2010

Volltextzugriff (PDF)

Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward

Clinical cancer research, 2006-06, Vol.12 (12), p.3661-3697

2006

Volltextzugriff (PDF)

Celecoxib Modulates the Capacity for Prostaglandin E2 and Interleukin-10 Production in Alveolar Macrophages from Active Smokers

Clinical cancer research, 2003-12, Vol.9 (16), p.5835-5841

2003

Volltextzugriff (PDF)

Lung cancer chemoprevention with celecoxib in former smokers

Cancer prevention research (Philadelphia, Pa.), 2011-07, Vol.4 (7), p.984-993

2011

Volltextzugriff (PDF)

Enriching the Molecular Definition of the Airway Field of Cancerization: Establishing New Paradigms for the Patient at Risk for Lung Cancer

Cancer prevention research (Philadelphia, Pa.), 2013-01, Vol.6 (1), p.4-7

2013

Volltextzugriff (PDF)

A Cytokine-Delivering Polymer Is Effective in Reducing Tumor Burden in a Head and Neck Squamous Cell Carcinoma Murine Model

Otolaryngology-head and neck surgery, 2014-09, Vol.151 (3), p.447-453

2014

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Female
(33)
Life Sciences & Biomedicine
(33)
Humans
(32)
Middle Aged
(23)
Aged
(19)
Oncology
(18)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Adult
(12)
Animals
(10)
Lung Neoplasms - Pathology
(9)
Mice
(9)
Aged, 80 And Over
(8)
Neoplasm Staging
(8)
Antineoplastic Agents
(7)
Carcinoma, Non-Small-Cell Lung - Pathology
(7)
Celecoxib
(7)
Pharmacology. Drug Treatments
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma

Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma

Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis

Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices

Characteristics of Lung Cancers Harboring NRAS Mutations

Aromatase inhibitors in human lung cancer therapy

A Phase I Trial to Determine the Optimal Biological Dose of Celecoxib when Combined with Erlotinib in Advanced Non–Small Cell Lung Cancer

Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 + T-cell Infiltration

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer

COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California

Regression of Recurrent Respiratory Papillomatosis With Celecoxib and Erlotinib Combination Therapy

Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma

Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers

Challenge and opportunity of targeted lung cancer chemoprevention

Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer

Gene Expression Alterations in the Bronchial Epithelium of e-Cigarette Users

Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer

Randomized phase 2 trial of erlotinib in combination with high‐dose celecoxib or placebo in patients with advanced non‐small cell lung cancer

Modulation of Pulmonary Leukotriene B4 Production by Cyclooxygenase-2 Inhibitors and Lipopolysaccharide

Histopathologic findings of HPV and p16 positive HNSCC

Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward

Celecoxib Modulates the Capacity for Prostaglandin E2 and Interleukin-10 Production in Alveolar Macrophages from Active Smokers

Lung cancer chemoprevention with celecoxib in former smokers

Enriching the Molecular Definition of the Airway Field of Cancerization: Establishing New Paradigms for the Patient at Risk for Lung Cancer

A Cytokine-Delivering Polymer Is Effective in Reducing Tumor Burden in a Head and Neck Squamous Cell Carcinoma Murine Model

Aktive Filter

Suchergebnisse filtern